BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Belli LS, Duvoux C, Karam V, Adam R, Cuervas-Mons V, Pasulo L, Loinaz C, Invernizzi F, Patrono D, Bhoori S, Ciccarelli O, Morelli MC, Castells L, Lopez-Lopez V, Conti S, Fondevila C, Polak W. COVID-19 in liver transplant recipients: preliminary data from the ELITA/ELTR registry. Lancet Gastroenterol Hepatol. 2020;5:724-725. [PMID: 32505228 DOI: 10.1016/s2468-1253(20)30183-7] [Cited by in Crossref: 40] [Cited by in F6Publishing: 23] [Article Influence: 20.0] [Reference Citation Analysis]
Number Citing Articles
1 Liaquat H, Shupp B, Rollins S, Schneider Y, Matin A. Comparison of the impact of chronic corticosteroid therapy on critical care outcomes of COVID-19 patients with and without history of chronic liver disease. Sci Rep 2021;11:19245. [PMID: 34584170 DOI: 10.1038/s41598-021-98778-z] [Reference Citation Analysis]
2 Yadav DK, Adhikari VP, Ling Q, Liang T. Immunosuppressants in Liver Transplant Recipients With Coronavirus Disease 2019: Capability or Catastrophe?-A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:756922. [PMID: 34859012 DOI: 10.3389/fmed.2021.756922] [Reference Citation Analysis]
3 Dhampalwar S, Saigal S, Choudhary N, Saraf N, Bhangui P, Rastogi A, Thiagrajan S, Soin AS. Outcomes of Coronavirus Disease 2019 in Living Donor Liver Transplant Recipients. Liver Transpl. 2020;26:1665-1666. [PMID: 33021025 DOI: 10.1002/lt.25909] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
4 Soin AS, Choudhary NS, Yadav SK, Saigal S, Saraf N, Rastogi A, Bhangui P, Srinivasan T, Mohan N, Saha SK, Gupta A, Chaudhary RJ, Yadav K, Dhampalwar S, Govil D, Gupta N, Vohra V. Restructuring Living Donor Liver Transplantation at a High Volume Center During the COVID-19 Pandemic. J Clin Exp Hepatol. 2020;. [PMID: 33052181 DOI: 10.1016/j.jceh.2020.09.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
5 Cococcia S, Lenti MV, Santacroce G, Achilli G, Borrelli de Andreis F, Di Sabatino A. Liver-spleen axis dysfunction in COVID-19. World J Gastroenterol 2021; 27(35): 5919-5931 [PMID: 34629809 DOI: 10.3748/wjg.v27.i35.5919] [Reference Citation Analysis]
6 Fonseca EA, Feier F, Pugliese R, Freitas AF, Porta G, Miura I, Baggio V, Kondo M, Benavides M, Vincenzi R, Roda K, Oliveira CV, Chapchap P, Seda-Neto J. Pediatric liver transplantation activity in a high-volume program during the COVID-19 pandemic in Brazil. Pediatr Transplant 2021;:e14112. [PMID: 34396644 DOI: 10.1111/petr.14112] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Fraser J, Mousley J, Testro A, Smibert OC, Koshy AN. Clinical Presentation, Treatment, and Mortality Rate in Liver Transplant Recipients With Coronavirus Disease 2019: A Systematic Review and Quantitative Analysis. Transplant Proc 2020;52:2676-83. [PMID: 32891405 DOI: 10.1016/j.transproceed.2020.07.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
8 Muñoz Serrano A, Arias A, Moreno-Torres V, Calderón J, Vicente N, Cuervas-Mons V. Coronavirus Disease 2019 (COVID-19) in Solid Organ Transplant Recipients: A Case-Control Study. Ann Transplant 2021;26:e933152. [PMID: 34764235 DOI: 10.12659/AOT.933152] [Reference Citation Analysis]
9 Belsky JA, Tullius BP, Lamb MG, Sayegh R, Stanek JR, Auletta JJ. COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients. J Infect 2021;82:329-38. [PMID: 33549624 DOI: 10.1016/j.jinf.2021.01.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
10 Gupta M, Manek G, Dombrowski K, Maiwall R. Newer developments in viral hepatitis: Looking beyond hepatotropic viruses. World J Meta-Anal 2021; 9(6): 522-542 [DOI: 10.13105/wjma.v9.i6.522] [Reference Citation Analysis]
11 Mansoor E, Perez A, Abou-Saleh M, Sclair SN, Cohen S, Cooper GS, Mills A, Schlick K, Khan A. Clinical Characteristics, Hospitalization, and Mortality Rates of Coronavirus Disease 2019 Among Liver Transplant Patients in the United States: A Multicenter Research Network Study. Gastroenterology 2021;160:459-462.e1. [PMID: 33010251 DOI: 10.1053/j.gastro.2020.09.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
12 Thuluvath PJ, Alukal JJ, Ravindran N, Satapathy SK. What GI Physicians Need to Know During COVID-19 Pandemic. Dig Dis Sci 2021;66:2865-75. [PMID: 33015748 DOI: 10.1007/s10620-020-06625-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
13 Dawood RM, Salum GM, El-Meguid MA. The Impact of COVID-19 on Liver Injury: COVID-19 and Liver Injury. Am J Med Sci 2021:S0002-9629(21)00400-6. [PMID: 34752738 DOI: 10.1016/j.amjms.2021.11.001] [Reference Citation Analysis]
14 Dorfman L, Nassar R, Rozenfeld Bar-Lev M, Shafir M, Oseran I, Mozer-Glassberg Y, Gavish R, Assa A, Shamir R, Waisbourd-Zinman O. Treatment adherence and behavior of pediatric liver transplant recipients during the COVID-19 pandemic. Pediatr Transplant 2022;:e14250. [PMID: 35146853 DOI: 10.1111/petr.14250] [Reference Citation Analysis]
15 Mathiasen VD, Oversoe SK, Ott P, Jensen-Fangel S, Leth S. Recovery of Moderate Coronavirus Disease 2019 in a Liver Transplant Recipient on Continued Immunosuppression: A Case Report. Transplant Proc 2020;52:2703-6. [PMID: 33039144 DOI: 10.1016/j.transproceed.2020.09.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
16 Webb GJ, Marjot T, Cook JA, Aloman C, Armstrong MJ, Brenner EJ, Catana MA, Cargill T, Dhanasekaran R, García-Juárez I, Hagström H, Kennedy JM, Marshall A, Masson S, Mercer CJ, Perumalswami PV, Ruiz I, Thaker S, Ufere NN, Barnes E, Barritt AS 4th, Moon AM. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study. Lancet Gastroenterol Hepatol 2020;5:1008-16. [PMID: 32866433 DOI: 10.1016/S2468-1253(20)30271-5] [Cited by in Crossref: 77] [Cited by in F6Publishing: 47] [Article Influence: 38.5] [Reference Citation Analysis]
17 Koike H, Okumura T, Murohara T, Katsuno M. Multidisciplinary Approaches for Transthyretin Amyloidosis. Cardiol Ther 2021. [PMID: 34089151 DOI: 10.1007/s40119-021-00222-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Kulkarni AV, Tevethia HV, Premkumar M, Arab JP, Candia R, Kumar K, Kumar P, Sharma M, Rao PN, Reddy DN. Impact of COVID-19 on liver transplant recipients-A systematic review and meta-analysis. EClinicalMedicine 2021;38:101025. [PMID: 34278287 DOI: 10.1016/j.eclinm.2021.101025] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
19 Zecher BF, Buescher G, Willemse J, Walmsley M, Taylor A, Leburgue A, Schramm C, Lohse AW, Sebode M. Prevalence of COVID-19 in patients with autoimmune liver disease in Europe: A patient-oriented online survey. United European Gastroenterol J 2021. [PMID: 34105883 DOI: 10.1002/ueg2.12100] [Reference Citation Analysis]
20 Gaspar R, Castelo Branco C, Macedo G. Liver and COVID-19: From care of patients with liver diseases to liver injury. World J Hepatol 2021; 13(10): 1367-1377 [PMID: 34786172 DOI: 10.4254/wjh.v13.i10.1367] [Reference Citation Analysis]
21 Russo FP, Izzy M, Rammohan A, Kirchner VA, Di Maira T, Belli LS, Berg T, Berenguer MC, Polak WG. Global impact of the first wave of COVID-19 on liver transplant centers: A multi-society survey (EASL-ESOT/ELITA-ILTS). J Hepatol 2021:S0168-8278(21)02107-3. [PMID: 34653592 DOI: 10.1016/j.jhep.2021.09.041] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Boettler T, Marjot T, Newsome PN, Mondelli MU, Maticic M, Cordero E, Jalan R, Moreau R, Cornberg M, Berg T. Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 mo of the pandemic. JHEP Rep. 2020;2:100169. [PMID: 32835190 DOI: 10.1016/j.jhepr.2020.100169] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 21.0] [Reference Citation Analysis]
23 Weiss MJ, Hornby L, Foroutan F, Belga S, Bernier S, Bhat M, Buchan CA, Gagnon M, Hardman G, Ibrahim M, Luo C, Luong ML, Mainra R, Manara AR, Sapir-Pichhadze R, Shalhoub S, Shaver T, Singh JM, Srinathan S, Thomas I, Wilson LC, Wilson TM, Wright A, Mah A. Clinical Practice Guideline for Solid Organ Donation and Transplantation During the COVID-19 Pandemic. Transplant Direct 2021;7:e755. [PMID: 34514110 DOI: 10.1097/TXD.0000000000001199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Philips CA, Rela M, Soin AS, Gupta S, Surendran S, Augustine P. Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients. J Clin Transl Hepatol 2021;9:947-59. [PMID: 34966658 DOI: 10.14218/JCTH.2021.00228] [Reference Citation Analysis]
25 De Carlis R, Vella I, Incarbone N, Centonze L, Buscemi V, Lauterio A, De Carlis L. Impact of the COVID-19 pandemic on liver donation and transplantation: A review of the literature. World J Gastroenterol 2021; 27(10): 928-938 [PMID: 33776364 DOI: 10.3748/wjg.v27.i10.928] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
26 Mocchegiani F, Baroni GS, Vivarelli M. Mild impact of SARS-CoV-2 infection on the entire population of liver transplant recipients: the experience of an Italian Centre based in a high-risk area. Updates Surg 2020;72:1291-3. [PMID: 32914336 DOI: 10.1007/s13304-020-00881-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Choudhury A, Reddy GS, Venishetty S, Pamecha V, Shasthry SM, Tomar A, Mitra LG, Prasad VST, Mathur RP, Bhattacharya D, Sarin SK. COVID-19 in Liver Transplant Recipients - A Series with Successful Recovery. J Clin Transl Hepatol 2020;8:467-73. [PMID: 33447532 DOI: 10.14218/JCTH.2020.00061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 Loinaz-Segurola C, Marcacuzco-Quinto A, Fernández-Ruiz M. Coronavirus disease 2019 in liver transplant patients: Clinical and therapeutic aspects. World J Hepatol 2021; 13(10): 1299-1315 [PMID: 34786167 DOI: 10.4254/wjh.v13.i10.1299] [Reference Citation Analysis]
29 Kullar R, Patel AP, Saab S. COVID-19 in Liver Transplant Recipients. J Clin Transl Hepatol 2021;9:545-50. [PMID: 34447684 DOI: 10.14218/JCTH.2020.00098] [Reference Citation Analysis]
30 Wong GL, Wong VW, Thompson A, Jia J, Hou J, Lesmana CRA, Susilo A, Tanaka Y, Chan WK, Gane E, Ong-Go AK, Lim SG, Ahn SH, Yu ML, Piratvisuth T, Chan HL;  Asia-Pacific Working Group for Liver Derangement during the COVID-19 Pandemic. Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement. Lancet Gastroenterol Hepatol. 2020;5:776-787. [PMID: 32585136 DOI: 10.1016/s2468-1253(20)30190-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
31 Agrawal D, Saigal S. Utilization of SARS-COV-2 positive donors and recipients for Liver transplantation in the pandemic era – An evidence-based review. Journal of Liver Transplantation 2022. [DOI: 10.1016/j.liver.2022.100081] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]